NEWS & MEDIA

Amryt Pharma Plc – TR-1: Standard Form for Notification of Major Holdings

11 October 2017

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

 

Amryt Pharma plc

 

 

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an “X” if appropriate)

 

2. Reason for the notification (please mark the appropriate box or boxes with an “X”)

 

An acquisition or disposal of voting rights

 

X

 

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights (increase of capital/placing)

 

X

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

 

Name

 

Software AG – Stiftung (Foundation)

 

City and country of registered office (if applicable)

Darmstadt, Germany
 

4. Full name of shareholder(s) (if different from 3.)v

 

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

 

11 October 2017

 

6. Date on which issuer notified (DD/MM/YYYY):

 

11 October 2017

 

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

 

% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)  

Total number of voting rights of isiuervii

 

Resulting situation on the date on which threshold was crossed or reached

22.3% N/A 22.3% 274,817,283
 

Position of previous notification (if

applicable)

N/A N/A N/A

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

 

A: Voting rights attached to shares

 

 

Class/type of
shares

ISIN code (if possible)

 

Number of voting rightsix

 

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

 

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

 

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

 

GB00BDD1LS57

 

61,272,920

 

0

 

22.3%

 

0%

 

SUBTOTAL 8. A

61,272,960 22.3%
 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

 

Type of financial instrument

 

Expiration
date
x

 

Exercise/
Conversion Period
xi

 

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights
SUBTOTAL 8. B 1
 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

 

Type of financial instrument Expiration
date
x
Exercise/
Conversion Period 
xi
Physical or cash

settlementxii

Number of voting rights % of voting rights
SUBTOTAL 8.B.2
 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an “X”)

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X
 

Namexv

 

% of voting rights if it equals or is higher than the notifiable threshold

 

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold
 

Software AG – Stiftung (Foundation)

22.3% N/A 22.3%
 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

 

N/A

 

The number and % of voting rights held

 

N/A

 

The date until which the voting rights will be held

 

N/A

 

11. Additional informationxvi

 

N/A

 

Place of completion London Stock Exchange, AIM
 

Date of completion

11 October 2017

 

This information is provided by RNS

The company news service from the London Stock Exchange

c.